Chiesi Ventures

The main department of described VC is located in the Boston. The venture was found in North America in United States.

Besides them, we counted 1 critical employee of this fund in our database.

The real fund results show that this VC is 9 percentage points less often commits exit comparing to other companies. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2014. This Chiesi Ventures works on 18 percentage points less the average amount of lead investments comparing to the other organizations.

The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Chiesi Ventures, startups are often financed by Caixa Capital Risc, Ysios Capital, Healthequity. The meaningful sponsors for the fund in investment in the same round are Ysios Capital, Sanderling Ventures, Roche Venture Fund. In the next rounds fund is usually obtained by Ysios Capital, Sanderling Ventures, Sambrinvest.

Among the various public portfolio startups of the fund, we may underline Minoryx Therapeutics, VelosBio, 4D Molecular Therapeutics The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Pharmaceutical, Therapeutics.

Notable deals

Review

• No reviews are submitted yet.